Distinct roles of ligand affinity and cytoskeletal anchorage in α_IIbβ₃ (GP IIb/IIIa)-mediated cell aggregation and adhesion

References

• Ruggeri Z M. Platelets in atherothrombosis. Nat Med 2002; 8: 1227–34.
   PubMed Web of Science ®Google Scholar
• Hynes R O. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673–87.
   PubMed Web of Science ®Google Scholar
• Peter K, O’Toole T E. Modulation of cell adhesion by changes in alpha L beta 2 (LFA-1, CD11a/CD18) cyto- plasmic domain/cytoskeleton interaction. J Exp Med 1995; 181: 315–26.
   PubMed Web of Science ®Google Scholar
• Ylanne J, Huuskonen J, O’Toole T E, Ginsberg M H, Virtanen I, Gahmberg C G. Mutation of the cytoplasmic domain of the integrin beta 3 subunit. Differential effects on cell spreading, recruitment to adhesion plaques, endocytosis, and phagocy- tosis. J Biol Chem 1995; 270: 9550–7.
   PubMed Web of Science ®Google Scholar
• Takagi J, Petre B M, Walz T, Springer T A. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002; 110: 599–11.
   PubMed Web of Science ®Google Scholar
• Shattil S J. Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways. Thromb Haemost 1999; 82: 318–25.
   PubMed Web of Science ®Google Scholar
• Ylanne J, Hormia M, Jarvinen M, Vartio T, Virtanen I. Platelet glycoprotein IIb/IIIa complex in cultured cells. Localization in focal adhesion sites in spreading HEL cells. Blood 1988; 72: 1478–86.
   PubMed Web of Science ®Google Scholar
• O’Toole T E, Katagiri Y, Faull R J, Peter K, et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994; 124: 1047–59.
   PubMed Web of Science ®Google Scholar
• Wagner C L, Mascelli M A, Neblock D S, Weisman H F, Coller B S, Jordan R E. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996; 88: 907–14.
   PubMed Web of Science ®Google Scholar
• Arnaout M A, Goodman S L, Xiong J P. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol 2002; 14: 641–51.
   PubMed Web of Science ®Google Scholar
• Du X P, Plow E F, Frelinger A L, 3rd, O’Toole T E, Loftus J C, Ginsberg M H. Ligands ‘activate’ integrin alpha IIb beta 3 (platelet GPIIb-IIIa). Cell 1991; 65: 409–16.
   PubMed Web of Science ®Google Scholar
• Peter K, Schwarz M, Ylanne J, et al. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood 1998; 92: 3240–9.
   PubMed Web of Science ®Google Scholar
• Kouns W C, Fox C F, Lamoreaux W J, Coons L B, Jennings LK. The effect of glycoprotein IIb-IIIa receptor occupancy on the cytoskeleton of resting and activated platelets. J Biol Chem 1991; 266: 13891–900.
   PubMed Web of Science ®Google Scholar
• Fox J E, Shattil S J, Kinlough-Rathbone R L, Richardson M, Packham M A, Sanan D A. The platelet cytoskeleton stabilizes the interaction between alphaIIbbeta3 and its ligand and induces selective movements of ligand-occupied integrin. J Biol Chem 1996; 271: 7004–11.
   PubMed Web of Science ®Google Scholar
• Tadokoro S, Shattil S J, Eto K, et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003; 302: 103–6.
   PubMed Web of Science ®Google Scholar
• Ylanne J, Chen Y, O’Toole T E, Loftus J C, Takada Y, Ginsberg M H. Distinct functions of integrin alpha and beta subunit cytoplasmic domains in cell spreading and formation of focal adhesions. J Cell Biol 1993; 122: 223–33.
   PubMed Web of Science ®Google Scholar
• Wang N, Butler J P, Ingber D E. Mechanotransduction across the cell surface and through the cytoskeleton. Science 1993; 260: 1124–7.
   PubMed Web of Science ®Google Scholar
• Geiger B, Bershadsky A, Pankov R, Yamada K M. Transmembrane crosstalk between the extracellular matrix–cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2001; 2: 793–805.
   PubMed Web of Science ®Google Scholar
• Calderwood D A, Ginsberg M H. Talin forges the links between integrins and actin. Nat Cell Biol 2003; 5: 694–7.
   PubMed Web of Science ®Google Scholar
• Boudignon-Proudhon C, Patel P M, Parise L V. Phorbol ester enhances integrin alpha IIb beta 3-dependent adhesion of human erythroleukemic cells to activation-dependent mono- clonal antibodies. Blood 1996; 87: 968–76.
   PubMed Web of Science ®Google Scholar
• Ylanne J, Cheresh D A, Virtanen I. Localization of beta 1, beta 3, alpha 5, alpha v, and alpha IIb subunits of the integrin family in spreading human erythroleukemia cells. Blood 1990; 76: 570–7.
   PubMed Web of Science ®Google Scholar
• Olorundare O E, Simmons S R, Albrecht R M. Cytochalasin D and E: effects on fibrinogen receptor movement and cytoskel- etal reorganization in fully spread, surface-activated platelets: a correlative light and electron microscopic investigation. Blood1992; 79: 99–109.
   Google Scholar
• Addo J B, Bray P F, Grigoryev D, Faraday N, Goldschmidt- Clermont P J. Surface recruitment but not activation of integrin alpha IIb beta 3 (GPIIb-IIIa) requires a functionalactin cytoskeleton. Arterioscler Thromb Vasc Biol 1995; 15: 1466–73.
   PubMed Web of Science ®Google Scholar
• Danilov Y N, Juliano R L. Phorbol ester modulation of integrin-mediated cell adhesion: a postreceptor event. J Cell Biol 1989; 108: 1925–33.
   PubMed Web of Science ®Google Scholar
• Faull R J, Kovach N L, Harlan J M, Ginsberg M H. Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: two mechanisms with divergent biological consequences. J Exp Med 1994; 179: 1307–16.
   PubMed Web of Science ®Google Scholar
• Lotz M M, Burdsal C A, Erickson H P, McClay D R. Cell adhesion to fibronectin and tenascin: quantitative measure- ments of initial binding and subsequent strengthening response. J Cell Biol 1989; 109: 1795–805.
   PubMed Web of Science ®Google Scholar
• Burn P, Kupfer A, Singer S J. Dynamic membrane- cytoskeletal interactions: specific association of integrin and talin arises in vivo after phorbol ester treatment of periph- eral blood lymphocytes. Proc Natl Acad Sci USA 1988; 85:497–501.
   PubMed Web of Science ®Google Scholar
• Kucik D F, Dustin M L, Miller J M, Brown E J. Adhesion- activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest 1996; 97: 2139–44.
   PubMed Web of Science ®Google Scholar
• O’Toole T E, Loftus J C, Du X P, et al. Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regul 1990; 1: 883–93.
   PubMedGoogle Scholar
• Tadokoro S, Shattil S J, Eto K, et al. Talin binding to integrin beta tails: A final common step in integrin activation. Science 2003; 302: 103–6.
   PubMed Web of Science ®Google Scholar
• Huttenlocher A, Ginsberg M H, Horwitz A F. Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol 1996; 134: 1551–62.
   PubMed Web of Science ®Google Scholar
• Wu C, Keivens V M, O’Toole T E, McDonald J A, Ginsberg M H. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 1995; 83: 715–24.
   PubMed Web of Science ®Google Scholar
• Chen Y P, O’Toole T E, Ylanne J, Rosa J P, Ginsberg M H. A point mutation in the integrin beta 3 cytoplasmic domain (S752!P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa). Blood 1994; 84: 1857–65.
   PubMed Web of Science ®Google Scholar
• Wang R, Shattil S J, Ambruso D R, Newman P J. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex. J Clin Invest 1997; 100:2393–403.
   PubMed Web of Science ®Google Scholar
• Nurden A T. Inherited abnormalities of platelets. Thromb Haemost 1999; 82: 468–80.
   PubMed Web of Science ®Google Scholar
• Hughes P E, O’Toole T E, Yla¨ nne J, Shattil S J, Ginsberg M H. The conserved membrane-proximal region of an integrin cytoplasmic domain specifies ligand binding affinity. J Biol Chem 1995; 270: 12411–17.
   PubMed Web of Science ®Google Scholar
• Hughes P E, Diaz-Gonzalez F, Leong L, et al. Breaking the integrin hinge. J Biol Chem 1996; 271: 6571–4.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Watson S P. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003; 102: 449–61.
   PubMed Web of Science ®Google Scholar
• Bombeli T, Schwartz B R, Harlan J M. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa- dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 1998; 187: 329–39.
   PubMed Web of Science ®Google Scholar
• Massberg S, Brand K, Gruner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196: 887–96.
   PubMed Web of Science ®Google Scholar
• Gawaz M. Do platelets trigger atherosclerosis? Thromb Haemost 2003; 90: 971–2.
   PubMed Web of Science ®Google Scholar
• Quinn M J, Byzova T V, Qin J, Topol E J, Plow E F. Integrin aIIbb3 and its antagonism. Arterioscler Thromb Vasc Biol 2003; 23: 945–52.
   PubMed Web of Science ®Google Scholar
• Bhatt D L, Topol E J. Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2003; 2: 15–28.
   PubMed Web of Science ®Google Scholar
• Shattil S J, Hoxie J A, Cunningham M, Brass L F. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107–14.Dabadie M, Valli N, Jacobin M J, Laroche-Traineau J, Barat J L, Ducassou D, Nurden A T, Clofent-Sanchez G. Characterisation, cloning and sequencing of a conformation-dependent monoclonal antibody to the alphaIIbbeta3 integrin: interest for use in thrombus detection. Platelets 2001; 12: 395–405.Jacobin M J, Laroche-Traineau J, Little M, Keller A, Peter K, Welschof M, Nurden A, Clofent-Sanchez G. Human IgG monoclonal anti-alpha(IIb)beta(3)-binding fragments derived from immunized donors using phage display. J Immunol 2002;168:2035–45.
   PubMedGoogle Scholar
• Schwarz M, Roettgen P, Takada Y, Little M, Bode C, Peter K. Generation and affinity maturation of synthetic conformation- specific single-chain antibodies against GPIIb/IIIa for a new therapeutic anti-platelet strategy. Circulation 2003; 108:1092.
   Web of Science ®Google Scholar